And We Have Another Double. Frontier Bio (FBIO) Crosses $4.00.
Sometimes we Can't Beleive Our Luck Over the Last Couple Years. But There You Have it, at Least we Know It's...
Aphex BioCleanse Hand Sanitizer Seeking FDA GRAS Approval.
Aphex BioCleanse Systems Enters Agreement with Now Biopharma for Hand Sanitizer Clinical Trial
PITTSFORD, N.Y., Aug. 31, 2020 /PRNewswire/ -- Aphex...
Video: What to Look for in Public Company Management.
In this episode MicroCapClub interviews author and fund manager Michael Shearn.
Michael discusses management teams that focus on solving...
Peleton (PTON) Hits $25 Billion Valuation. Calm (Private) Hits Unicorn Valuation at $1 Billion.
Home Fitness and Wellness Raging on Main Street and Wall Street.
While 24 Hour Fitness Files for Bankruptcy..
Immunomedics (IMMU) $3.00 to $88, Up 29-fold, Our Second Best Idea Ever.
Interesting Charts From the Day we Discovered it.
Gilead Sciences, Inc. (Nasdaq: GILD) and Immunomedics (Nasdaq: IMMU) announced...
American BriVision’s (ABVC) Clinical Study Sparks Interest From Potential Partners.
Is Wall Street Missing American Brivision's Full Clinical Safety and Efficacy Study? We Think it has.
Potential...
Mitesco Inc. Initiates “The Good Clinic” Rollout in Minneapolis; Introduces the Founders of “The...
MINNEAPOLIS, MN, Sept. 14, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Mitesco, Inc. (OTCQB: MITI) today announced that The Good Clinic, LLC has filed...
Aphex BioCleanse Systems (APHX) Plans Filing With Securities & Exchange Commission.
Aphex BioCleanse Systems Appoints Hancock Askew as New PCAOB-Qualified Auditor, Hires Accounting Consultant
PITTSFORD, N.Y., Sept 14, 2020 /PRNewswire/ -- Aphex...
Adding Sorrento Therapeutics (SRNE) to CoronaVirus Watch List.
LIVE QUOTE
Of course, we need not have to say, this is not an idea for widows...
Telehealth: How the Pandemic Forced Mental Health Care to Change for the Better (Vox).
New therapy options were desperately needed before the pandemic
Two facts overshadow all discussions of mental health care...
Latest article
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
GeoVax (GOVX) Launches Vaccine Manufacturing System.
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production...
